Apatinib (100 mg/kg/day) alone was found to significantly inhibit the growth and angiogenesis of transplanted tumors in three NSCLC nude mice models, and the inhibitory effect of apatinib combined with EGFR‐TKI in H1975 xenograft was apparent. Here, EGFR is linked to non-small cell lung carcinoma.